Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
43.65
+2.00 (4.80%)
At close: Jan 21, 2026, 4:00 PM EST
43.00
-0.65 (-1.49%)
After-hours: Jan 21, 2026, 7:27 PM EST
Twist Bioscience Market Cap
Twist Bioscience has a market cap or net worth of $2.67 billion as of January 21, 2026. Its market cap has decreased by -4.80% in one year.
Market Cap
2.67B
Enterprise Value
2.53B
1-Year Change
-4.80%
Ranking
Category
Stock Price
$43.65
Market Cap Chart
Since October 31, 2018, Twist Bioscience's market cap has increased from $372.54M to $2.67B, an increase of 617.94%. That is a compound annual growth rate of 31.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 2.67B | 37.89% |
| Dec 31, 2025 | 1.94B | -29.68% |
| Dec 31, 2024 | 2.76B | 29.75% |
| Dec 29, 2023 | 2.13B | 57.83% |
| Dec 30, 2022 | 1.35B | -64.93% |
| Dec 31, 2021 | 3.84B | -43.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RadNet | 5.44B |
| Sotera Health Company | 5.31B |
| GRAIL | 3.95B |
| BillionToOne | 3.93B |
| Veracyte | 3.30B |
| GeneDx Holdings | 2.88B |
| Neogen | 2.03B |
| NeoGenomics | 1.64B |